Katori M - Search Results

1

A stable metabolite, Arg-Pro-Pro-Gly-Phe, of bradykinin in the degradation pathway in human plasma.

Shima C, Majima M, Katori M. Shima C, et al. Among authors: katori m. Jpn J Pharmacol. 1992 Oct;60(2):111-9. doi: 10.1254/jjp.60.111. Jpn J Pharmacol. 1992. PMID: 1479739 Free article.

2

Increase in the kinin levels in the bronchial washings after intravenous injection of leukotriene C4 in guinea pigs.

Majima M, Jin HY, Katori M, Sunahara N. Majima M, et al. Among authors: katori m. Agents Actions Suppl. 1992;38 ( Pt 3):467-74. Agents Actions Suppl. 1992. PMID: 1462880

3

Evidence for the involvement of a plasma kallikrein-kinin system in the immediate hypotension produced by endotoxin in anaesthetized rats.

Katori M, Majima M, Odoi-Adome R, Sunahara N, Uchida Y. Katori M, et al. Br J Pharmacol. 1989 Dec;98(4):1383-91. doi: 10.1111/j.1476-5381.1989.tb12688.x. Br J Pharmacol. 1989. PMID: 2692754 Free PMC article.

4

Oxytocin-induced natriuresis mediated by the renal kallikrein-kinin system in anesthetized male rats.

Adachi K, Majima M, Katori M, Nishijima M. Adachi K, et al. Among authors: katori m. Jpn J Pharmacol. 1995 Mar;67(3):243-52. doi: 10.1254/jjp.67.243. Jpn J Pharmacol. 1995. PMID: 7630042 Free article.

5

Diuretic and natriuretic effect of ebelactone B in anesthetized rats by inhibition of a urinary carboxypeptidase Y-like kininase.

Majima M, Kuribayashi Y, Ikeda Y, Adachi K, Kato H, Katori M, Aoyagi T. Majima M, et al. Among authors: katori m. Jpn J Pharmacol. 1994 May;65(1):79-82. doi: 10.1254/jjp.65.79. Jpn J Pharmacol. 1994. PMID: 8089934 Free article.

6

Detection of the degradation products of bradykinin by enzyme immunoassays as markers for the release of kinin in vivo.

Majima M, Sunahara N, Harada Y, Katori M. Majima M, et al. Among authors: katori m. Biochem Pharmacol. 1993 Feb 9;45(3):559-67. doi: 10.1016/0006-2952(93)90127-i. Biochem Pharmacol. 1993. PMID: 8442755

7

Poststatin, a novel inhibitor of bradykinin-degrading enzymes in rat urine.

Majima M, Shima C, Saito M, Kuribayashi Y, Katori M, Aoyagi T. Majima M, et al. Among authors: katori m. Eur J Pharmacol. 1993 Mar 2;232(2-3):181-90. doi: 10.1016/0014-2999(93)90772-a. Eur J Pharmacol. 1993. PMID: 8467857

8

Failure of the oxytocin-induced increase in secretion of urinary kallikrein in young spontaneously hypertensive rats.

Majima M, Adachi K, Ohno T, Ogino M, Saito M, Kizuki K, Katsumata O, Yamashina S, Katori M. Majima M, et al. Among authors: katori m. Jpn J Pharmacol. 1996 May;71(1):11-9. doi: 10.1254/jjp.71.11. Jpn J Pharmacol. 1996. PMID: 8791167 Free article.

9

Pivotal role of renal kallikrein-kinin system in the development of hypertension and approaches to new drugs based on this relationship.

Katori M, Majima M. Katori M, et al. Jpn J Pharmacol. 1996 Feb;70(2):95-128. doi: 10.1254/jjp.70.95. Jpn J Pharmacol. 1996. PMID: 8866749 Free article. Review.

10

Inhibition of kinin degradation on the luminal side of renal tubules reduces high blood pressure in deoxycorticosterone acetate salt-treated rats.

Nakajima S, Ito H, Hayashi I, Kuribayashi Y, Okumura T, Yajima Y, Katori M, Majima M. Nakajima S, et al. Among authors: katori m. Clin Exp Pharmacol Physiol. 2000 Jan-Feb;27(1-2):80-7. doi: 10.1046/j.1440-1681.2000.03209.x. Clin Exp Pharmacol Physiol. 2000. PMID: 10696533

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters